Array BioPharma Inc. (NASDAQ:ARRY): Stochastic Analysis


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Array BioPharma Inc. (NASDAQ:ARRY) for the period of 9-Day stands at 59.11% while the stochastic %D for the same period stands at 71.79%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Array BioPharma Inc. (NASDAQ:ARRY) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Hold”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Sell” for Array BioPharma Inc. (NASDAQ:ARRY) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently Array BioPharma Inc. (NASDAQ:ARRY)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. The company’s proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas.

Previous Day Activity Analysis

On the last trading day, Array BioPharma Inc. (NASDAQ:ARRY) opened the session at $10.78 and after going up 1.66% closed at $11. The stock gained 0.22 points in the last trade.

Array BioPharma Inc. (NASDAQ:ARRY)’s stock fluctuated in the range of $10.67 and $11.05 during the previous active session. Array BioPharma Inc. (NASDAQ:ARRY) traded with the volume of 1.84 Million with average volume of 4.25 Million. The stock has LOW volatility on the last trading session.

Currently the Beta for the company remains at 1.92 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.45 and 48.56 respectively.

Currently the Insider Ownership of the shares of Array BioPharma Inc. (NASDAQ:ARRY) is at 0.21% and the shares outstanding are 193.8 Million.

Important Ratio Analysis

Some important ratios to consider here for Array BioPharma Inc. (NASDAQ:ARRY) are discussed below:

Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The Price to Sale P/S and Price to Book P/B shows the value of 15.09 and 8.46 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 4.6 and 0 correspondingly.

The Quick Ratio of Array BioPharma Inc. (NASDAQ:ARRY) stands at 5.4 while the Current Ratio depicts the value of 5.4.

Return on Assets ROA of Array BioPharma Inc. (NASDAQ:ARRY) is at -38.5% whereas, Return on Equity ROE and Return of Investment ROI of Array BioPharma Inc. (NASDAQ:ARRY) stand at -158.7% and -71.1% respectively.

Stock Performance Analysis

The stock performance of Array BioPharma Inc. (NASDAQ:ARRY) on the basis of 5 day trade show the dip of -1.17% whereas, the monthly performance of the stock shows decrease of -11.58%.

The quarterly performance of the stock remained in green zone with the value of 22.09% while six month performance of the shares of Array BioPharma Inc. (NASDAQ:ARRY) remained bullish with the count of 33.82%.

The yearly and YTD performance of Array BioPharma Inc. (NASDAQ:ARRY) remained up at 63.45% and 25.14% respectively.